Evidence map›Paper›PMID 32895212›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2020

[Positive lymph node ratio ≥0.16 is an independent risk factor affecting the prognosis of patients with esophageal cancer].

Wenzhu Yao, Ning Lu, Manli Cui, Jia Wang, Zhaozhao Du, Mingxin Zhang

Abstract read
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wenzhu YaoXi'an Medical University, Xi'an 710032, China.
Ning LuDepartment of Gastroenterology, First Affiliated Hospital of Xi'an Medical University, Xi'an 710077, China.
Manli CuiDepartment of Gastroenterology, First Affiliated Hospital of Xi'an Medical University, Xi'an 710077, China.
Jia WangDepartment of Gastroenterology, First Affiliated Hospital of Xi'an Medical University, Xi'an 710077, China.
Zhaozhao DuDepartment of Gastroenterology, First Affiliated Hospital of Xi'an Medical University, Xi'an 710077, China.
Mingxin ZhangDepartment of Gastroenterology, First Affiliated Hospital of Xi'an Medical University, Xi'an 710077, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the value of positive lymph node ratio (LNR) in predicting the prognosis of patients with esophageal cancer.

methodsWe retrieved the data of a total of 862 patients with esophageal cancer with complete clinical pathology data archived in SEER database in 2010 to 2015. The best cutoff point of LNR was selected using X-tile software. Univariate and multivariate COX proportional hazard models were used to assess the value of LNR in predicting the prognosis of patients after propensity score matching (PSM).

resultsThe best cut-off point of LNR determined using X-tile 3.6.1 software was 0.16. The patients with LNR < 0.16 and those with LNR≥0.16 showed significant differences in the number of positive lymph nodes, pathological type, T stage and M stage. After 1:1 propensity score matching, the two groups showed no significant difference in the clinical data or pathological parameters. Matched univariate and multivariate COX regression analyses showed that LNR, primary tumor site and M staging were all independent risk factors affecting the prognosis of patients, and among them LNR had the most significant predictive value (LNR < 0.16

conclusionsLNR≥0.16 is an independent risk factor affecting the prognosis of patients with esophageal cancer and has better prognostic value than N stage.

Indexed as

Esophageal NeoplasmsLymph NodesHumansLymphatic MetastasisLymph Node ExcisionLymph Node RatioNeoplasm StagingPrognosisRetrospective StudiesRisk Factorsesophageal cancerpositive lymph node ratioprognosisSEER database

Identifiers

PMID32895212
PMCPMC7321281

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.